Loading...
XNYS
EHAB
Market cap472mUSD
Dec 05, Last price  
9.33USD
1D
0.21%
1Q
19.77%
IPO
-58.97%
Name

Enhabit Inc

Chart & Performance

D1W1MN
XNYS:EHAB chart
P/E
P/S
0.46
EPS
Div Yield, %
Shrs. gr., 5y
66.70%
Rev. gr., 5y
-1.07%
Revenues
1.03b
-1.10%
1,092,000,0001,078,200,0001,106,600,0001,083,100,0001,046,300,0001,034,800,000
Net income
-156m
L+94.04%
24,000,00075,000,000111,100,00062,500,000-80,500,000-156,200,000
CFO
51m
+5.79%
59,500,00024,900,000123,300,00080,100,00048,400,00051,200,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
IPO date
Jun 23, 2022
Employees
10,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT